The industry once regarded September as the four-fold confirmation period for domestic policies and corporate profits. Many policies in the pharmaceutical manufacturing industry will be implemented in September. These new policies and regulations will affect the entire industry, every company, and every medical person. The following author briefly counts, in September, the earth-shaking changes that will take place in the pharmaceutical manufacturing industry.
"Administrative Measures for Medical Consumables in Medical Institutions (Trial)" was officially implemented
From September 1, the "Administrative Measures for Medical Consumables in Medical Institutions (Trial)" jointly issued by the National Health Commission and the State Administration of Traditional Chinese Medicine will be implemented.
The "Measures" make relevant requirements for management objects, management content, consumables procurement and management systems. Among these requirements, medical institutions should implement relevant regulations on the disclosure of hospital affairs, include major medical consumables in the scope of active disclosure, and disclose relevant information such as brand specifications, supply companies, and prices.
This also means that the procurement of medical consumables will be more transparent and open, and the industry will be further regulated, which will help reduce the burden on patients.
Centralized procurement and expansion, gradually expanding to the whole country
On September 1, Shanghai Sunshine Pharmaceutical Network announced the "Documents for Centralized Procurement of Medicines in the Alliance Region". The expansion of centralized procurement will be launched in 25 regions including Shanxi, Inner Mongolia, Liaoning, Jilin, Heilongjiang, Jiangsu, Zhejiang, etc., involving the first batch of 25 winning products in the pilot program, and introducing the new “multiple winning bids” regulations. .
According to the arrangement, this round of procurement will be opened in Shanghai on September 24. The application materials will be received at 8:30 in the morning, and the submission and declaration information will be closed at 10:00 in the morning. The supply area will be confirmed at 2:00 in the afternoon. The results are expected to be available on the same day.
With the gradual expansion of the scope of centralized drug procurement to the whole country, it is conducive to further reducing the price of drugs and reducing the burden of drugs for patients in my country.
|
